Kathleen E. Kearney

Kathleen E. Kearney

Auto-generated profile, based on publicly available information

Kathleen E. Kearney

Division of Cardiology, Department of Medicine University of Washington Seattle Washington USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
ARAthanasios Rempakos
Athanasios Rempakos
MAMichaella Alexandrou
Michaella Alexandrou
BSBahadir Simsek
Bahadir Simsek
SKSpyridon Kostantinis
Spyridon Kostantinis
JKJudit Karacsonyi
Judit Karacsonyi
EBEmmanouil Brilakis
Emmanouil Brilakis

17 March 2017 in Current Atherosclerosis Reports
Verified
Journal Article
Closed access
PDF file
KKKathleen Kearney
Kathleen Kearney
RHRavi S. Hira
Ravi S. Hira
RRRobert F. Riley
Robert F. Riley
AKArun Kalyanasundaram
Arun Kalyanasundaram
WLWilliam L. Lombardi
William L. Lombardi

1 April 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
ACAmy E. Cheney
Amy E. Cheney
LVLogan L. Vincent
Logan L. Vincent
JMJames M. McCabe
James M. McCabe
KKKathleen E. Kearney
Kathleen E. Kearney
Concerns over radiation exposure are ubiquitous to all interventional cardiologists; however, fear of exposure during childbearing years disproportionately deters women from entering the field. This review summarizes the available data on occupational radiation exposure during pregnancy with an emphasis on radiation quantification, the impact of exposure at various stages of fetal development, societal recommendations for safe levels of exposure during gestation, threshold levels necessary to induce fetal harm, and safe practices for the pregnant interventionalist. Reconciling the available information, we conclude that pregnancy in the cardiac catheterization laboratory is both safe and feasible. This review also highlights new technologies that may augment standard radiation safety techniques and are of particular interest to the pregnant interventional cardiologist. Finally, we propose steps to improve female representation in this field, underscoring the importance of a sex-balanced workforce.

1 December 2018 in Resuscitation
Verified
Journal Article
Closed access
KKKathleen E. Kearney
Kathleen E. Kearney
CMCharles Maynard
Charles Maynard
BSBryn Smith
Bryn Smith
TRThomas D. Rea
Thomas D. Rea
ABAlexis Beatty
Alexis Beatty
JMJames M. McCabe
James M. McCabe

26 November 2025 in JACC
Verified
Journal Article
Closed access
LALorenzo Azzalini
Lorenzo Azzalini
KKKathleen Kearney
Kathleen Kearney
ASAdam C. Salisbury
Adam C. Salisbury
NSNancy Stone
Nancy Stone
KGKensey L. Gosch
Kensey L. Gosch
THTaishi Hirai
Taishi Hirai

30 January 2022 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
YHYasin Hussain
Yasin Hussain
KKKathleen E. Kearney
Kathleen E. Kearney
JAJ. Dawn Abbott
J. Dawn Abbott
DKDean J. Kereiakes
Dean J. Kereiakes
CMCarlo Di Mario
Carlo Di Mario
ALAlexandra J. Lansky
Alexandra J. Lansky
Coronary artery calcification increases the procedural complexity of percutaneous coronary intervention and is associated with worse outcomes, especially in women. Intravascular lithotripsy (IVL) has been demonstrated to be safe and effective for vessel preparation in severely calcified stenotic lesions before stent implantation. Sex-based outcomes of IVL-facilitated stenting have not been defined. We performed a patient-level pooled analysis of the 4 prospective, single-arm Disrupt CAD studies that evaluated the safety and efficacy of IVL-facilitated stenting. Patient baseline and procedural characteristics and clinical outcomes were examined based on sex. The primary safety end point was 30-day major adverse cardiovascular events, defined as the composite of cardiac death, myocardial infarction, or target vessel revascularization. The primary efficacy end point was procedural success, defined as stent delivery with residual in-stent stenosis ≤30% without in-hospital major adverse cardiovascular events. A total of 628 patients were included, of which 144 (22.9%) were women. Women were older (P < .001) and more likely to have hyperlipidemia (P = .03), renal insufficiency (P = .05), and prior myocardial infarction (P = .05). Women had smaller mean reference vessel diameter (2.7 ​ ± ​0.4 ​mm vs 3.0 ​ ± ​0.5 ​mm, P < .001), shorter lesion length (22.4 ​ ± ​10.3 ​mm vs 25.0 ​ ± ​11.7 ​mm, P = .01), and less side branch involvement (22.9% vs 32.4%, P = .03). Severe coronary calcification defined by angiography, stent delivery success, lesion predilatation, post-IVL dilatation, and poststent dilatation was similar between groups. There were no significant differences between women and men in the primary safety end point (8.3% vs 7.1%, P = .61; adjusted odds ratio 1.66; 95% confidence interval 0.78, 3.34; P = .17) or the primary efficacy end point (91.7% vs 92.6%, P = .72; adjusted odds ratio 0.58; 95% confidence interval 0.29, 1.24; P = .15). Post-IVL serious angiographic complications (flow-limiting dissection, perforation, abrupt closure, slow flow, no reflow) were similar for women and men (1.6% vs 2.3%, P = .75). Despite more comorbidities and smaller vessel size, IVL-facilitated stenting of severely calcified lesions achieves similar safety and efficacy in women and men.